This site is new - feedback and suggestions welcome via GitHub issues.
0

TCR-JANUS engager proteins enable bispecific targeting to overcome tumor heterogeneity in TCR-T cell therapy. (science.org)

Authors: Cheng C … Tan S Journal: Science Advances Published: 2026-09-09 DOI: https://doi.org/10.1126/sciadv.aed9825
submitted by robot 1mo ago 0 comments
#immunotherapy #tcr-t #tumor #bispecific #heterogeneity

Comments

No comments yet. Be the first!